Cryo-Cell International, Inc. CCEL
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +46.80%
- 1 year
- +11.97%
- Market cap
- 40.72M
- Revenue (ttm)
- 31.84M
- Profit margin
- -28.04%
- EPS (ttm)
- -0.24
- Shares out
- 8.06M
- Forward P/E
- 96.63
- Dividend
- 1.00 (12.77%)
- Ex-dividend date
- Nov 14, 2024
- YTD return
- +46.80%
- 1-year return
- +11.97%
- Volume
- 6.52K
- Avg volume
- 24.56K
- Open
- 5.00
- Previous close
- 5.35
- Day's range
- 5.05 – 5.35
- 52-week range
- 2.72 – 5.45
- Beta
- 0.51
- Price target
- 9.00 (+78.2%)
2Y -2.02 (-27.41%)
Key statistics
- Enterprise value
- 72.73M
- PEG ratio
- 0.00
- Price / sales
- 1.96
- Price / book
- 0.00
- Dividend yield
- 12.77%
- Payout ratio
- 0.00%
- Revenue growth
- 2.50%
- Free cash flow
- -4.78M
- Total cash
- 2.13M
- Total debt
- 11.73M
- Return on equity
- 0.00%
- Short % of float
- 0.38%
- 50-day average
- 7.71
- 200-day average
- 7.47
Analyst view
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.02.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 15, 2024 | Aug 1, 2024 | 0.00 | 0.13 | — | — |
| Jul 15, 2024 | May 1, 2024 | 0.00 | 0.08 | — | — |
| Apr 15, 2024 | Feb 1, 2024 | 0.00 | 0.07 | — | — |
| Feb 28, 2024 | Nov 1, 2023 | 0.00 | 0.26 | — | — |
| Oct 12, 2023 | Aug 1, 2023 | 0.00 | 0.08 | — | — |
| Jul 14, 2023 | May 1, 2023 | 0.00 | 0.03 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 29, 2022 | Maxim Group | init | — | Buy |
About Cryo-Cell International, Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- cryo-cell.com
News
12 Health Care Stocks Moving In Friday's Intraday Session 
Goodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into Monday 
Goodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into Monday 
Cryo-Cell International Q3 EPS $0.16 Up From $0.09 YoY, Sales $7.820M Down From $7.830M YoY 
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket 
Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoY 
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results 
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on CCEL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MIKULINSKY OLEG | Chief Technology Officer | Conversion of Exercise of derivative security | Nov 11, 2024 | 188,698 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Hamilton Lane Advisors Llc | 3.62% | 409,734 | 3.17M | Sep 29, 2024 |
| SFI Advisors, LLC | 1.46% | 165,300 | 1.28M | Sep 29, 2024 |
| Vanguard Group Inc | 1.03% | 116,848 | 903.24K | Sep 29, 2024 |
| MassMutual Trust Company FSB/ADV | 0.98% | 111,035 | 858.30K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.35% | 39,860 | 308.12K | Sep 29, 2024 |
| Northern Trust Corporation | 0.19% | 21,836 | 168.79K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.85% | 95,611 | 739.07K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.20% | 22,852 | 176.65K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.19% | 21,237 | 164.16K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.11% | 12,415 | 95.97K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.08% | 8,884 | 68.67K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 5,408 | 41.80K | Oct 30, 2024 |